• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

MicroRNAs (miRNAs) are small regulatory molecules post-transcriptionally suppressing
mRNA activity. Many miRNAs in various organisms have been cloned but many unknown …

Abstract Aim The “2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management
of Patients With Atrial Fibrillation” provides recommendations to guide clinicians in the …

Background Despite improvements in the management of atrial fibrillation, patients with this
condition remain at increased risk for cardiovascular complications. It is unclear whether …

Despite marked progress in the management of atrial fibrillation (AF), detecting AF remains
difficult and AF-related complications cause unacceptable morbidity and mortality even on …

Aims A strategy of systematic, early rhythm control (ERC) improves cardiovascular outcomes
in patients with atrial fibrillation (AF). It is not known how this outcome-reducing effect is …

Background Few studies evaluated the impact of catheter ablation (CA) on atrial
tachyarrhythmia (ATA) burden in paroxysmal atrial fibrillation (AF). Objective In the …

The first edition of Europace journal in 1999 came right around the time of the landmark
publication of the electrophysiologists from Bordeaux, establishing how elimination of …

Objectives: This study sought to determine the prevalence of patients with 4 isolated veins at
repeat ablation after “CLOSE”-guided pulmonary vein isolation (PVI), a strategy based on …

Aims The risk of developing atrial fibrillation (AF) and its complications continues to
increase, despite good progress in preventing AF-related strokes. Methods and results This …